In ctDNA analysis of our case 2, we detected a reduction in the TP53 (E286K) mutation level after NAC treatment, while another TP53 (V216M) mutation level was increased, which might enhance the populational change of TP53-mutated cancer cells. Here, TP53 is linked to cancer.